Visionquest Biomedical

Albuquerque, NM 87106
http://visionquest-bio.com

SBIR Award Summary

Total Number of Awards 47
Total Value of Awards $16.8MM
First Award Date 07/01/07
Most Recent Award Date 09/01/17

Key Personnel

Last Name Name Awards Contact
Edwards Anne Edwards 1
Barriga Eduardo Simon Barriga 4
Pattichis Marios S Pattichis 3
Yu Honggang Yu 1
Posse Stefan Posse 1
Soliz Peter Soliz Soliz 30
JOSHI VINAYAK S JOSHI 8
MCGOWEN SUSAN MCGOWEN 1
LEWALLEN SUSAN LEWALLEN 4
BAUMAN WENDALL C BAUMAN 3
CAPONE ANTONIO CAPONE 1
BURGE MARK R BURGE 3
HARDING SIMON HARDING 2
FINK BRANDI C FINK 1
ZAMORA GILBERTO ZAMORA 2
MANIVANNAN NIRANCHANA MANIVANNAN 1

47 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-058
Budget: 09/01/17 - 08/31/18

Summary The objective of this project is to validate the i-RxTherm?, VisionQuest?s patented functional thermal imaging system that produces biomarkers for early detection of diabetic peripheral neuropathy (DPN). This device is based on the principle that changes in microvascular function are correlated to quantifiable changes in nerve function a...

Phase SBIR

Agency: Department of Health & Human Services
Topic: PAR-16-027
Budget: 09/01/17 - 08/31/18

Summary VisionQuest Biomedical LLC (VisionQuest) has developed a diabetic retinopathy (DR) screening system (EyeStar?) enabled by automated screening software (DR-RACS) that was developed under the EY018280 Phase II SBIR project. Our product provides immediate feedback to the physician on the state of diabetic eye disease without burdening an ey...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 06/01/17 - 05/31/18

? DESCRIPTION (provided by applicant): Cerebral malaria (CM) is a life-threatening neurological complication associated with malarial infection. Malaria affects about 198 million people worldwide, and claims 584,000 lives annually, 75% of whom are African children under 5 years of age. CM is mistakenly over- diagnosed about 23% of the time, i...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 03/01/17 - 02/28/18

Summary The objective of this project is to develop the Comprehensive Eye Evaluation Algorithm (CEEvA), a system to achieve blindness prevention in a cost effective way. CEEvA uses fundus images and available personal medical data in the electronic medical record (medical history and laboratory tests) to automatically screen not only for DR, but...

Phase SBIR

Agency: Department of Health & Human Services
Topic: PAR-16-027
Budget: 09/30/16 - 08/31/17

Summary VisionQuest Biomedical LLC (VisionQuest) has developed a diabetic retinopathy (DR) screening system (EyeStar?) enabled by automated screening software (DR-RACS) that was developed under the EY018280 Phase II SBIR project. Our product provides immediate feedback to the physician on the state of diabetic eye disease without burdening an ey...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-058
Budget: 09/22/16 - 08/31/17

Summary The objective of this project is to validate the i-RxTherm?, VisionQuest?s patented functional thermal imaging system that produces biomarkers for early detection of diabetic peripheral neuropathy (DPN). This device is based on the principle that changes in microvascular function are correlated to quantifiable changes in nerve function a...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 09/01/16 - 03/31/18

? DESCRIPTION (provided by applicant): In the US, there are 720,000 annual incidences of heart attack, out of which 515,000 are first time heart attacks. Risk factors for cardiovascular disease (CVD) are thought to be well-defined, but they do not identify all at-risk individuals. Therefore, there is a need to detect other factors that provid...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 09/01/16 - 08/31/17

? DESCRIPTION (provided by applicant): In the US, there are 720,000 annual incidences of heart attack, out of which 515,000 are first time heart attacks. Risk factors for cardiovascular disease (CVD) are thought to be well-defined, but they do not identify all at-risk individuals. Therefore, there is a need to detect other factors that provid...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 06/10/16 - 05/31/17

? DESCRIPTION (provided by applicant): Alcohol misuse is a significant public health problem, not only in the US but around the world. Just in the US, alcohol misuse is estimated to be the second cause of preventable death at a cost of more than $220 billion in a single year. Further, it is also estimated that it reduces the lives of those who...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 06/01/16 - 05/31/17

? DESCRIPTION (provided by applicant): This Phase II project is motivated by current issues associated with screening for retinopathy of prematurity (ROP). ROP is the leading cause of blindness in infants. In recent years the number of infants at risk for ROP has been increasing. In the United States, the rate of prematurity has risen from 9.4...

Load More